2-206693184-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001093730.1(DYTN):c.971C>T(p.Ala324Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000683 in 1,610,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001093730.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYTN | NM_001093730.1 | c.971C>T | p.Ala324Val | missense_variant | 9/12 | ENST00000452335.2 | NP_001087199.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYTN | ENST00000452335.2 | c.971C>T | p.Ala324Val | missense_variant | 9/12 | 1 | NM_001093730.1 | ENSP00000396593.2 | ||
DYTN | ENST00000674258.1 | n.1282C>T | non_coding_transcript_exon_variant | 10/15 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000205 AC: 5AN: 243854Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132360
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1458182Hom.: 0 Cov.: 30 AF XY: 0.00000965 AC XY: 7AN XY: 725282
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2024 | The c.971C>T (p.A324V) alteration is located in exon 9 (coding exon 9) of the DYTN gene. This alteration results from a C to T substitution at nucleotide position 971, causing the alanine (A) at amino acid position 324 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at